The nominating institute Weizmann Institute of Science on the project:
Currently, there is not a single treatment available for Alzheimer’s disease. Schwartz’s breakthrough therapy harnesses the power of the immune system to protect and repair the brain. It’s expected to provide the first disease-modifying treatment in Alzheimer’s and dementia. Her technology was licensed to a biopharma company, and is currently under expedited development.